NCT04617522 2026-02-11Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver ImpairmentGilead SciencesPhase 1 Recruiting30 enrolled
NCT05143229 2025-10-06ASSETUniversity of Kansas Medical CenterPhase 1 Active not recruiting18 enrolled